{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01436201","recordId":"NCT01436201","peptideSlug":"dulaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01436201-dulaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01436201.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01436201.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-09-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2011-09-15","publishedAt":"2026-08-23","recordId":"NCT01436201","recordSha256":"d042025e073971c0ff50873b6a744ef6c1516ab862decfb193b888792ad998cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01436201?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2011-10-07","publishedAt":"2026-08-23","recordId":"NCT01436201","recordSha256":"2396e90f081b5ef34c1ef4b221bd5bf7b96283869a9cdda46e9a0ed95756063d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01436201?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2012-01-10","publishedAt":"2026-08-23","recordId":"NCT01436201","recordSha256":"e682e3ea12b689facda0c464e50e6cf83d765fb487a8a95ce5285712c8681f9f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01436201?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2012-04-02","publishedAt":"2026-08-23","recordId":"NCT01436201","recordSha256":"42befbd6b8797e0aaf2f417cbb0a266e6591476119875371630c21bd106e59f3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01436201?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2014-10-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2014-10-03","publishedAt":"2026-08-23","recordId":"NCT01436201","recordSha256":"5f8075fae980bdfff19eaaf51fdb89e3c823fd251f2133dccac21614efd7d684","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01436201?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d3e8d85a2298d45f3526ce89ee435791abc48765e5162684b04ddc3704c30db3"}}